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Dengue is an acute viral disease caused by any of
four dengue virus serotypes (DEN 1–4). A small propor-
tion of infected persons may develop the severe form of
disease, dengue haemorrhagic fever (DHF) and dengue
shock syndrome (DSS). All over 99% of the cases of vi-
ral haemorrhagic fever reported worldwide are related to
DHF1. Dengue fever (DF) has great variability of clinical
features, which depends on many factors such as person,
place and time2–3. It may be confused clinically with other
infections, viz. influenza, measles, typhoid, leptospirosis
and any non-specific viral syndromes4.
Tirupur town in Tamil Nadu is a leading foreign ex-
change earning centre in India. It has a residential popu-
lation of about 0.35 million living in an area of about
27.2 km2. Water scarcity occurs frequently and the local
residents of Tirupur are storing water for atleast seven
days in order to manage their daily needs, which leads to
high breeding of Aedes aegypti (Diptera: Culicidae). DF
is not endemic in Tirupur. Number of suspected dengue
cases were reported periodically in the past three years
but no case was diagnosed serologically. In July 2005, a
case of DHF identified in Tirupur, a major epidemic en-
sured, moving briskly through a number of sub-urbans.
We surveyed four areas in Tirupur where the sus-
pected dengue outbreak occurred. Case records of all the
notified cases admitted to the hospitals including Gov-
ernment and private hospitals in the region were collected.
The demographic data consisting of age, gender, local-
ity, patient complaints, clinical examination in detail and
laboratory data (blood, urine, chest X-ray and USG) were
collected. Patients admitted with a provisional diagnosis
of dengue or suspected dengue were followed up through-
out their hospital stay. A detailed history of the patients
was collected and a thorough clinical examination was
carried out. Blood specimens were collected for CBC,
LFT and dengue confirmation. Daily physical examina-
tion by paediatrician and CBC findings were recorded.
The cases were classified as ‘probable’ on the basis of
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clinical findings. Clinical diagnosis was made based on
the WHO 1997 case definition criteria for DF/DHF/DSS.
Classification of definite cases required laboratory inves-
tigations and virus isolation. The study was carried out after
getting informed consent from the parents or guard-
ians. Statistical analysis was carried out by using SPSS
version 11.5.
A total of 152 patients clinically diagnosed as prob-
able dengue fever were identified during this outbreak.
The mean age of the patients was 23.5 yr (1 to 48). The
mean duration of symptoms prior to admission was three
days. About 22 (14.4%) were aged <1 yr, 37 (24.4%)
Table 1. Clinical findings during Tirupur epidemic of dengue
Symptoms No. of cases Percentage
Fever 148 97.4
Retro-orbital pain/puffiness 95 62.5
Vomiting 82 53.9
Headache 88 57.9
Myalgia 86 56.6
Arthralgia 86 56.6
Rash 82 21.1
Tourniquet test 43 53.9
Petechiae, ecchymosis, purpura 44 28.9
Haematemesis 26 17.1
Rapid weak pulse 31 20.4
Narrow pulse pressure 29 19.1
Hypotension 57 37.5
Cold, clammy skin 39 25.7
Pain abdomen 36 23.7
Pruritis 36 23.7
Giddiness 25 16.4
Spleen/liver enlargement 48 31.6
Platelet count* 71 46.7
WBC count* 72 47.4
Hb/PCV* 73 48
LFT* 55 36.2
Chest X-ray* 25 16.4
Ultrasound abdomen* 25 16.4
Fully recovered 148 97.4
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were under 5 yr, 69 (45.39%) were in the age group of
6–15 yr and 24 (15.8%) were >16 yr old. The mean dura-
tion of hospital stay was found to be 4.5 (range 1–15)
days. Males (90/152) remained most affected than females
(62/152).
An admission diagnosis of dengue fever was made in
34 cases and viral illness in remaining cases. Other admis-
sion diagnoses included chest infection or asthma (five
cases), gastroenteritis (two cases), encephalopathy (two
cases), enteric fever (two cases), and urinary tract infection
(one case). The symptoms recorded in the hospitalized pa-
tients are given in Table 1. Fever was documented in most
cases. About 52% had a maximum temperature of 40°C and
47% had a maximum temperature of 38°C. Patients who
did not have fever at the time of admission had been symp-
tomatic 2–7 days prior to admission and it was likely that
they mostly had been febrile during that period.
Headache, retro-orbital pain and musculoskeletal pain
were documented in 57.9% (children <5 yr were omitted
because they were unable to express their symptoms).
Rash was noticed only in 53.9%. GI symptoms like nau-
sea, vomiting (53.9%) and pain in abdomen in 23.7% was
noticed. There were 71 cases with low platelet count as
per WHO criteria for DHF/DSS. Patients who did not
satisfy all criteria for diagnosis of DHF, but had positive
serology were classified as DF. There were 46 cases that
fulfilled all the four WHO criteria for DHF/DSS.
Headache and musculoskeletal pain and gastrointes-
tinal symptoms, especially nausea, were very common.
The presence or absence of other symptoms was recorded
in less than half of the case records. The presence of al-
tered taste, ocular pain and pruritis were reported very
common. Bleeding of any severity was noted in 19 pa-
tients. Complications that were ascribed to dengue infec-
tion including ‘dehydration’ were noticed in 20 patients.
Treatment with intravenous fluids was often commenced
as a consequence of nausea.
Rash was described as being particularly severe in 29
patients, which appeared more in the extremities with florid
petechiae, frank haemorrhage and/or intense pruritis.
Bleeding was listed as a complication in 19 patients.
Amongst these patients, bleeding varied in severity from
gum bleeding to haematemesis, haematuria or melena.
There were 46 cases that fulfilled the WHO criteria
for DHF5 and 42 cases occurred in the children with
haematemesis and melena. The serological profile was
that of a primary dengue infection. Four young males
showed with a serological profile of secondary dengue
infection. Chest X-ray and ultrasonography done only in
hospitalized cases and 25 (26.8%) of them showed posi-
tive findings.
In all, 11 patients had measurements of hepatic tran-
saminases and 45% of these patients had levels, which
exceeded the laboratory normal range for aspartate tran-
saminase (AST) (NR <40 U/L). Alanine transaminase
(ALT) (NR <45 U/L) and γ-glutamyltransferase (GGT)
(NR <50 U/L) were elevated. AST was elevated in all of
the patients and three patients had AST levels that ex-
ceeded 1000 U/L. Urine analysis results were recorded in
137 of the patients and blood was detected in 5%6.
A total of 66 patients had probable primary dengue
and 34 probable secondary dengue virus infections. The
hospitalized patients with secondry infections were older
and less likely to have a rash associated with their illness.
The duration of stay in hospital (p >0.05) and other
manifestations of illness, including the incidence of
haemorrhagic phenomena and dual infection were very
high in the hospitalized group. Four children (three fe-
male and one male) all <5 yr were reported to be died due
to the haemorrhagic complications. This may be due to
the delay in hospital admission, diagnosis, consequence
of inadequate care and treatment.
Severe clinical manifestations with a high hospital-
ization rate characterized DENV-3 epidemics in Tirupur,
south India. Previous epidemics were not reported but
silent transmission of dengue virus was reported in 19987
with much lower hospitalization rates. Particular features
of the epidemic included a very high incidence of gas-
trointestinal manifestations, and a high incidence of un-
usually severe rash, in those patients who were hospital-
ized. Mostly in other cases the clinical features were
typical for dengue fever. The apparently low reported rates
of altered taste and pruritis are possibly a reflection on
the retrospective nature of the study. Many of doctors in
the hospital were unfamiliar with the clinical features of
dengue fever and did not enquire routinely about the pres-
ence of symptoms such as taste perversion and skin itch.
A large number of dengue cases were misdiagnosed based
on clinical findings since the symptoms are consistent
with other diseases.
Forty-two cases of DHF were documented in chil-
dren. The serological profile in this case was consistent
with a primary dengue infection. Four cases of DHF iden-
tified in young males, the serological profile in this case
was secondary dengue infection8–10. Overlapping in
major clinical features among DF and DHF is obscuring
the severity of this epidemic, it emphasized the need for
simple classification which is acceptable to all the regions.
The AST was elevated more often than the ALT,
which is a pattern that has been observed previously.
Hepatic disorders, in conjunction with bleeding and
thrombocytopaenia, have been proposed as an indicator 313 Thangaratham et al: Clinical picture of DHF in Tirupur
of severe disease11. Several patients had a clinical picture
dominated by their probable sub clinical hepatitis.
From our experience we could conclude that the cir-
culation of DENV-3 is responsible for the recent DHF
with low mortality. High morbidity of population and ur-
banization leads to circulation of multiple dengue sero-
types12–13 and development of severe DHF among paedi-
atrics in Tirupur. The mortality rate is low in the present
epidemic; it may increase in subsequent epidemics. Four
children who died had DSS and delayed in hospital ad-
mission. It emphasized that the children with high fever
should seek hospital treatment without any delay. Health
education regarding manifestations of DF is important
during epidemics. Results of the serological and virologi-
cal studies of this episode have been published else-
where14.
To conclude, this study shows that DF is expanding
wings with its severe manifestations, early treatment can
reduce the morbidity and mortality during epidemics.
Early detection and case management practices have been
noted as critical factors for survival. Yet well-targeted
operational research in these areas is rare. Population-
based epidemiological studies with clear operational ob-
jectives should be launched as concerted efforts at regional
levels. Health education and training of district level health
personnel regarding manifestations of DHF is important
during epidemics, which will help in early case detection
and treatment.
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